GSK Continues to Pay for Avandia Claims

Problems with Avandia continue to haunt GSK. Previously, GSK has settled thousands of claims over Avandia while claiming there is nothing wrong with the onetime diabetes wonder drug.  And now confronted with allegations brought by the State of Utah the drug giant defrauded the state’s Medicaid program through allegedly false and misleading marketing of Avandia, [...]

December 10th, 2013|Avandia Diabetes Drug, Drug and Medical Device Litigation|0 Comments

Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

Drugs, Advertising, and Risks Associated with Direct to Consumer Ads

If you have watched a news program, sporting event, or network television show recently you have seen multiple ads for drugs or devices that will change your life.  Whether it is “Larry the cable guy” for the “purple” pill, a handsome athletic looking couple looking for the right moment assisted by a “blue” pill, an [...]

October 23rd, 2013|Drug and Medical Device Litigation|0 Comments

Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures.  Currently there are over 10,000 pending cases in the [...]

Why Is the FDA Having Another Hearing on Avandia?

On June 5-6, 2013, the FDA will convene an advisory committee meeting on Avandia, a drug which was removed in most countries in 2010 and placed under severe restrictions in the US. Avandia, a project of GSK (GlaxoSmithkline), was the subject of extreme medical controversy and massive litigation in both the MDL and in State [...]